Investigation of HTTLPR gene polymorphism fluctuation in type II diabetes

Akerblom, 2002, Environmental factors in the etiology of type 1 diabetes, Am J Med Genet, 115, 18, 10.1002/ajmg.10340 Alberti, 1998, Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation, Diabet Med, 15, 539, 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S Peng, 2018, Serum carbohydrate antigen 153 and renal function in patients with type 2 diabetes mellitus, J Clin Lab Anal, 32, 10.1002/jcla.22461 American Diabetes Association, 2000, Type 2 diabetes in children and adolescents, Diabetes Care, 23, 381, 10.2337/diacare.23.3.381 Hansson, 2018, Secretagogin is increased in plasma from type 2 diabetes patients and potentially reflects stress and islet dysfunction, PLoS One, 13, 10.1371/journal.pone.0196601 American Diabetes Association, 2002, The prevention or delay of type 2 diabetes, Diabetes Care, 25, 742, 10.2337/diacare.25.4.742 Andrews, 1993, Sustained depletion of cortical and hippocampal serotonin and norepinephrine but not striatal dopamine by 1-methyl-4-(2’-aminophenyl)-1,2,3,6-tetrahydropyridine (2’-NH2-MPTP): a comparative study with 2’-CH3-MPTP and MPTP, J Neurochem, 60, 1167, 10.1111/j.1471-4159.1993.tb03271.x Assmann, 1988, The Prospective Cardiovascular Munster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease, Am Heart J, 116, 1713, 10.1016/0002-8703(88)90220-7 Barnett, 1981, Diabetes in identical twins. A study of 200 pairs, Diabetologia, 20, 87, 10.1007/BF00262007 Bard, 1993, Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylatecyclase, J Biol Chem, 268, 23422, 10.1016/S0021-9258(19)49479-9 Bennett, 1995 Bloom, 1975, Register of newly diagnosed diabetic children, BMJ, 3, 580, 10.1136/bmj.3.5983.580 Boulton, 1998, Diabetic neuropathy, Med Clin, 82, 909 Dujic, 2016, Effect of serotonin transporter 5-HTTLPR polymorphism on gastrointestinal intolerance to metformin: a GoDARTS Study, Diabetes Care, 39, 1896, 10.2337/dc16-0706 Yokoyama, 2015, The 5-HTTLPR variant in the serotonin transporter gene modifies degeneration of brain regions important for emotion in behavioral variant frontotemporal dementia, Neuroimage Clin, 9, 283, 10.1016/j.nicl.2015.07.017 Dujic, 2016, Effect of serotonin transporter 5-HTTLPR polymorphism on gastrointestinal intolerance to metformin: a GoDARTS study, Diabetes Care, 39, 1896, 10.2337/dc16-0706 Chiasson, 2002, Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial, Lancet, 359, 2072, 10.1016/S0140-6736(02)08905-5 Hameed, 2015, Genetic association analysis of serotonin transporter polymorphism (5-HTTLPR) with type 2 diabetes patients of Pakistani population, Diabetes Res Clin Pract, 108, 67, 10.1016/j.diabres.2015.01.009 Peralta-Leal, 2012, Association of a serotonin transporter gene (SLC6A4) 5-HTTLPR polymorphism with body mass index categories but not type 2 diabetes mellitus in Mexicans, Genet Mol Biol, 35, 589, 10.1590/S1415-47572012005000048 Iordanidou, 2010, The serotonin transporter promoter polymorphism (5-HTTLPR) is associated with type 2 diabetes, Clin Chim Acta, 411, 167, 10.1016/j.cca.2009.10.022 DECODE Study Group, 2001, Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria, Arch Intern Med, 161, 397, 10.1001/archinte.161.3.397 Petrisić, 1997, Monoamine transporter gene expression in the central nervous system in diabetes mellitus, J Neurochem, 68, 2435, 10.1046/j.1471-4159.1997.68062435.x